Abstract:Purpose This study aimed to predict the progression-free survival (PFS) of the patients who were diagnosed with hypopharyngeal cancer and received postoperative chemoradiotherapy by using multi-omics method which integrating clinical factors, dosimetric and radiomic features. Materials and methods This study retrospectively collected the pretreatment T1-weighted MR imaging data of 88 hypopharyngeal cancer patients with postoperative chemoradiotherapy, including 56 cases from one center (training and testing cohorts) and 32 cases from another center (external validation cohort), and the gross tumor volumes (GTV) were countered for all cases. A Python-based library, pyradiomics was used to extract the radiomics features from each GTV. Least absolute shrinkage and selection operator (LASSO) regression was used to identify the most important features for classifier establishment. On the other hand, complete radiotherapy data are retained for 48 patients among them, and the planning tumor volumes (PTV) were countered for radiotherapy planning. The dose distribution features extracted by using pyradiomics and the dosimetric parameters were combined with the radiomics features to establish the classifiers. The probabilities of positive sample calculated from the best classifier, the radiomics and multi-omics signatures were obtained for establish the Cox proportional hazards models. Results The ensemble learning (EL) model was selected as the superior model with the higher area under the receiver operating characteristic curve (AUC) values than other classifier during the radiomics-only analysis, and the EL model with stacking technique showed the best performance, yielding AUC values of 0.93, 0.79, and 0.78 for the training, testing, and external validation cohorts, respectively. Furthermore, the multi-omics analysis integrating radiomics and dosiomics improved the effectiveness of the EL model with AUC values of 0.98 and 0.88 for the training and testing cohorts, respectively. Furthermore, the C-index of the Cox proportional hazards models resulted in a 0.099 improvement in the testing cohort when employing the multi-omics signature versus the radiomics signature. Conclusion Regarding the patients with hypopharyngeal cancer receiving postoperative chemoradiotherapy, the multi-omics-based prognostic prediction could achieve a more robust predictive capability than the radiomics-only study. This approach warrants further validation through prospective studies.

An MRI-based radiomics-clinical nomogram for the overall survival prediction in patients with hypopharyngeal squamous cell carcinoma: a multi-cohort study

Prognostic Value of a CT Radiomics-Based Nomogram for the Overall Survival of Patients with Nonmetastatic BCLC Stage C Hepatocellular Carcinoma after Stereotactic Body Radiotherapy.

MRI Radiomics for Predicting Survival in Patients with Locally Advanced Hypopharyngeal Cancer Treated with Concurrent Chemoradiotherapy

MRI-based Radiomic Signature As Predictive Marker for Patients with Head and Neck Squamous Cell Carcinoma

A novel nomogram for predicting overall survival in patients with tongue squamous cell carcinoma using clinical features and MRI radiomics data: a pilot study

Prognostic value of the radiomics-based model in progression-free survival of hypopharyngeal cancer treated with chemoradiation

Multi-Omics-Based Prognostic Prediction for Locally Advanced Hypopharyngeal Cancer Treated with Surgery and Postoperative Chemoradiotherapy: A Dual-Center Study

An MRI-based radiomics signature and clinical characteristics for survival prediction in early-stage cervical cancer

Construction and Validation of a MRI‐Based Radiomic Nomogram to Predict Overall Survival in Patients with Local Advanced Cervical Cancer: A Multicenter Study

CT-based radiomics nomogram for overall survival prediction in patients with cervical cancer treated with concurrent chemoradiotherapy

Development of a Radiomics Nomogram Based on the MRI Features to Predict the Survival of Hepatocellular Carcinoma Patients

Computed Tomography-Based Radiomics Nomogram for Predicting the Postoperative Prognosis of Esophageal Squamous Cell Carcinoma: A Multicenter Study

Preoperative computed tomography-based tumoral radiomic features prediction for overall survival in resectable non-small cell lung cancer

MRI-Based Bone Marrow Radiomics Nomogram for Prediction of Overall Survival in Patients With Multiple Myeloma

Noninvasive prediction of residual disease for advanced high-grade serous ovarian carcinoma by MRI-based radiomic-clinical nomogram

A Radiomics Nomogram for Non-Invasive Prediction of Progression-Free Survival in Esophageal Squamous Cell Carcinoma

Radiomics Nomogram Based on Multiple-Sequence Magnetic Resonance Imaging Predicts Long-Term Survival in Patients Diagnosed With Nasopharyngeal Carcinoma

Preoperative prediction of cervical cancer survival using a high-resolution MRI-based radiomics nomogram

Development of a Radiomics Nomogram Based on the 2D and 3D CT Features to Predict the Survival of Non-Small Cell Lung Cancer Patients

MRI radiomics nomogram integrating postoperative adjuvant treatments in recurrence risk prediction for patients with early-stage cervical cancer

Comprehensive radiomics nomogram for predicting survival of patients with combined hepatocellular carcinoma and cholangiocarcinoma